U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

SRX21710854: GSM7770473: WX1 cells, with 50 mg/L doxycycline addition,rep3; Chryseobacterium sp.; RNA-Seq
1 ILLUMINA (Illumina NovaSeq 6000) run: 12M spots, 3.6G bases, 1.1Gb downloads

External Id: GSM7770473_r1
Submitted by: Peking university
Study: Analysis of differential gene expression in the degradation of doxycycline by Chryseobacterium sp. WX1
show Abstracthide Abstract
We isolated an efficient doxycycline degrading strain Chryseobacterium sp. WX1. To investigate gene expression patterns during doxycyclinedegradation by strain WX1, we conducted a comparative transcriptomic analysis using cultures of strain WX1 with and without doxycycline addition. The RNA-Seq data revealed that 90.44-96.56% of the reads mapped to the genome of Chryseobacterium sp. WX1 across all samples. Differentially expressed genes (DEGs) analysis (|log2FC| >2; p < 0.01) showed that 693 genes were significantly up-regulated and 592 genes were significantly down-regulated. Overall design: Control groups (WX1_CK): cultures of strain WX1 without doxycycline addition. Experimental groups (WX1_DOX):cultures of strain WX1 with 50 mg/L doxycycline.
Sample: WX1 cells, with 50 mg/L doxycycline addition,rep3
SAMN37339473 • SRS18846671 • All experiments • All runs
Library:
Name: GSM7770473
Instrument: Illumina NovaSeq 6000
Strategy: RNA-Seq
Source: TRANSCRIPTOMIC
Selection: cDNA
Layout: PAIRED
Construction protocol: Total RNA was extracted from the collected cells using TRIzol® Reagent (Invitrogen) and further purified using DNase I (TaKara). RNA-seq transcriptome library was prepared following TruSeqTM RNA sample preparation Kit from Illumina (San Diego, CA) using 2μg of total RNA.
Runs: 1 run, 12M spots, 3.6G bases, 1.1Gb
Run# of Spots# of BasesSizePublished
SRR2599308811,985,8473.6G1.1Gb2023-09-12

ID:
29380819

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...